New Test Outperforms CA-125 in Ovarian Cancer Detection

Moreover, CA-125 is currently being used to detect ovarian cancer. CA-125 is a protein that is found in the blood. In several women with ovarian cancer, high CA-125 levels can be seen. When researchers compared the Parasortix test with CA125, the Parasortix test showed nearly double specificity rates in comparison to that of CA125. Advantages of this system are seen in how easily CTCs are harvested and analyzed, how fast cancer cells are captured, and how the approach does not depend solely on the use of antibodies. Most important, the main competitive advantages to this system are seen in its accessibility, inexpensiveness, and specific detailing.